← Research library

The mechanisms of the neurotropic action of bromantan

Animal research · 1999

What was studied
Animal experiments and synaptosomal assays
Main finding
Experimental work examined dopamine, serotonin, and noradrenergic responses. These are mechanistic observations, not evidence of human cognitive or sleep benefits.

Rat neuroleptic antagonism · At 5 mg/kg

Reported findings and study design

Animal neurochemical and in-vitro synaptosome experiments.

Population or model Animal experiments and synaptosomal assays

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Rat neuroleptic antagonismAt 5 mg/kg
Dopamine/serotonin uptake blockAt 50 microM
Norepinephrine uptake blockAbove 500 microM
Mouse serotonergic behavioral effects1–20 mg/kg
Cat neuromuscular transmissionNo effect at 1–50 mg/kg IV
Central cholinergic effectsInhibition described at 30–600 mg/kg

Different species, routes and assay concentrations are not combined into a human potency estimate.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • Species, assays, and exposures differ from everyday human use.
  • A neurotransmitter-related signal does not establish a clinical mechanism or long-term safety.

Source details

PubMed record and English abstract checked.

Sources checked

Citation

Author affiliations · Institute of Pharmacology, Russian Academy of Medical Sciences, Moscow

Animal / experimentalEnglish abstract

I. S. Morozov, G. S. Pukhova, N. A. Avdulov, S. A. Sergeeva, A. A. Spasov, I. N. Iezhitsa. The mechanisms of the neurotropic action of bromantan Eksp Klin Farmakol. 62(1):11–14

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards